Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Other Net Income (Loss) : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shanxi Zhendong Pharmaceutical Co Other Net Income (Loss)?

Shanxi Zhendong Pharmaceutical Co's Other Net Income (Loss) for the three months ended in Mar. 2024 was ¥0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Shanxi Zhendong Pharmaceutical Co's quarterly Other Net Income (Loss) increased from Sep. 2023 (¥-0 Mil) to Dec. 2023 (¥0 Mil) and increased from Dec. 2023 (¥0 Mil) to Mar. 2024 (¥0 Mil).

Shanxi Zhendong Pharmaceutical Co's annual Other Net Income (Loss) declined from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥-0 Mil) but then increased from Dec. 2022 (¥-0 Mil) to Dec. 2023 (¥0 Mil).

Shanxi Zhendong Pharmaceutical Co Other Net Income (Loss) Historical Data

The historical data trend for Shanxi Zhendong Pharmaceutical Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanxi Zhendong Pharmaceutical Co Other Net Income (Loss) Chart

Shanxi Zhendong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Shanxi Zhendong Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Shanxi Zhendong Pharmaceutical Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Shanxi Zhendong Pharmaceutical Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Shanxi Zhendong Pharmaceutical Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

N/A

Address

Zhendong Technology Park, Guang Road, Changzhi County, Changzhi, CHN, SXI 047100

Website

http://en.zdjt.com

Shanxi Zhendong Pharmaceutical Co Ltd together with its subsidiaries, researches, develops, manufactures, and markets pharmaceutical products and Chinese medicines in China. It offers anticancer drugs, cardiovascular disease prevention and control drugs and anti-infection drugs among others. The company categorizes its product as Chinese & Western Medicine, Wuhe Food, Home Care Products and Traditional Chinese Medicine.

Executives

Miao Hui	Director
Ma Shi Feng	Executives
Li Zhi Xu	Executives
Li Xi Hai	Director
You Rong Li	Executives
Wang Xu Wen	Executives
Dong Mi Zhu	Directors, executives
Li Ren Hu	Supervisors
Ning Lu Hong	Directors, executives
Wang Li Qing	Supervisors
Jin Zhi Xiang	Supervisors

Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Headlines

No Headlines